Evidence map›Paper›PMID 33234108›Full record

ArticleBMC genetics2020

Identifying rare variants for quantitative traits in extreme samples of population via Kullback-Leibler distance.

Yang Xiang, Xinrong Xiang, Yumei Li

Abstract read
In one paragraph

Article in BMC genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yang XiangSchool of Mathematics and Computational Science, Huaihua University, Huaihua, Hunan, 418008, People's Republic of China.
Xinrong XiangSchool of Mathematics and Statistics, Hunan Normal University, Changsha, Hunan, 410081, People's Republic of China.
Yumei LiSchool of Mathematics and Computational Science, Huaihua University, Huaihua, Hunan, 418008, People's Republic of China. lymmail@126.com.ORCID 0000-0003-1755-4504

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe rapid development of sequencing technology and simultaneously the availability of large quantities of sequence data has facilitated the identification of rare variant associated with quantitative traits. However, existing statistical methods depend on certain assumptions and thus lacking uniform power. The present study focuses on mapping rare variant associated with quantitative traits.

resultsIn the present study, we proposed a two-stage strategy to identify rare variant of quantitative traits using phenotype extreme selection design and Kullback-Leibler distance, where the first stage was association analysis and the second stage was fine mapping. We presented a statistic and a linkage disequilibrium measure for the first stage and the second stage, respectively. Theory analysis and simulation study showed that (1) the power of the proposed statistic for association analysis increased with the stringency of the sample selection and was affected slightly by non-causal variants and opposite effect variants, (2) the statistic here achieved higher power than three commonly used methods, and (3) the linkage disequilibrium measure for fine mapping was independent of the frequencies of non-causal variants and simply dependent on the frequencies of causal variants.

conclusionsWe conclude that the two-stage strategy here can be used effectively to mapping rare variant associated with quantitative traits.

Indexed as

Chromosome MappingModels, GeneticQuantitative Trait, HeritableQuantitative Trait LociComputer SimulationLinkage DisequilibriumPhenotypeAssociation analysisExtreme phenotypeFine mappingQuantitative traitRare variant

Identifiers

PMID33234108
PMCPMC7687851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.